Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2009 |
| End Date: | April 2016 |
Primary Objective:
· The primary objective is to estimate the prevalence of use of complementary and
alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase
I clinic at MD Anderson Cancer Center (MDACC).
Secondary Objective:
· Examine the association between prevalence of CAM use and demographic and socioeconomic
characteristics (age, gender, race, income, and education level), participation in a phase I
clinical trial, disease characteristics (diagnosis), patients' perceptions about their
prognosis, physicians' information and permission for patients' CAM use, decision-making,
and types of CAM used by patients.
· The primary objective is to estimate the prevalence of use of complementary and
alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase
I clinic at MD Anderson Cancer Center (MDACC).
Secondary Objective:
· Examine the association between prevalence of CAM use and demographic and socioeconomic
characteristics (age, gender, race, income, and education level), participation in a phase I
clinical trial, disease characteristics (diagnosis), patients' perceptions about their
prognosis, physicians' information and permission for patients' CAM use, decision-making,
and types of CAM used by patients.
This survey study is intended to estimate the prevalence of use of CAM in patients who are
currently being treated in the Phase I Clinical Trials Program at University of Texas MD
Anderson Cancer Center. The survey includes questions about socioeconomic characteristics
(age, gender, race, income, and education level), patients' diagnosis and patients'
perceptions about their prognosis, physicians' information and permission for patients' use
of CAM, patients' use of CAM (yes or no), decision-making (purpose of CAM use), resources
and types of CAM.
Patients will be asked to drop the questionnaire into a box in a specified location after
completion of the questionnaire. Accrual is expected to be 50-100 patients per month. This
survey is expected to finish in 6 months.
currently being treated in the Phase I Clinical Trials Program at University of Texas MD
Anderson Cancer Center. The survey includes questions about socioeconomic characteristics
(age, gender, race, income, and education level), patients' diagnosis and patients'
perceptions about their prognosis, physicians' information and permission for patients' use
of CAM, patients' use of CAM (yes or no), decision-making (purpose of CAM use), resources
and types of CAM.
Patients will be asked to drop the questionnaire into a box in a specified location after
completion of the questionnaire. Accrual is expected to be 50-100 patients per month. This
survey is expected to finish in 6 months.
Inclusion Criteria:
1) Patients with a clinical diagnosis of malignancy who are seen in the outpatient
oncology clinic.
Exclusion Criteria:
1) Presence of any clinically relevant condition that, in the opinion of the investigator/
coordinator, would interfere with completing the study including, but not limited to,
visual problems, cognitive impairment or acute mental illness.
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
